Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




R-Biopharm and Merck Partner on Companion Diagnostics

By LabMedica International staff writers
Posted on 10 Apr 2016
R-Biopharm AG (Darmstadt, Germany) and Merck KGaA (Darmstadt, Germany) have entered into an agreement that constitutes their first collaboration, which will initially focus on developing and launching companion diagnostics.

Companion diagnostics play a central role in personalized medicine by helping to find specific therapies matching to individual patients and thereby improve patient care and reduce healthcare costs.

In addition to covering research, development, and launching of novel companion diagnostics, the project also provides a framework for further collaborations across a potentially wide range of therapeutic areas and a broad range of technologies.

"We are very pleased to partner with Merck KGaA, Darmstadt, Germany, one of the world's leading healthcare companies", said Dr. More...
Frank Apostel, vice president, Companion Diagnostics, R-Biopharm, a leading developer and provider of reliable test systems for clinical diagnostics and for analyzing human food and animal feedstuffs, "This partnership is an example to the level of expertise and service R-Biopharm is committed to delivering to our partners in companion diagnostics."

Financial terms of the agreement were not disclosed.

Related Links:

R-Biopharm
R-Biopharm Companion Diagnostics
Merck KGaA



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.